There are many different treatments for inflammatory bowel disease, and choosing the right one for a patient with a new diagnosis can be a challenge.

In a virtual presentation for the Interdisciplinary Autoimmune Summit, Adam Cheifetz, MD, director of the IBD center at Beth Israel Deaconess Medical Center, said to optimize therapy, physicians need to think about treating smarter, earlier, deeper, to a targeted goal and more effectively.

“At the time of diagnosis use certain clinical factors, including serology and genetics, and in our case endoscopy, to try to predict which patients are

Full Article: https://www.healio.com/news/gastroenterology/20200713/smarter-earlier-deeper-choosing-an-initial-ibd-therapy